US equities |
MU $953.19 ▲+0.00% SNDK $1,482.33 ▲+0.00% ASML $1,717.76 ▲+0.00% SKHY $157.06 ▲+0.00% INTC $102.81 ▲+0.00% NVDA $228.52 ▲+0.00% SPCX $156.54 ▲+0.00% AMD $605.53 ▲+0.00%
FinancialContent

Generate Biomedicines, Inc. - Common Stock (NQ:GENB)

12.26 -0.00 (-0.04%)
Delayed Quote Updated: 4:00 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Generate Biomedicines, Inc. - Common Stock

News headline image
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
From Generate Biomedicines, Inc.
Via GlobeNewswire
News headline image
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
From Generate Biomedicines, Inc.
Via GlobeNewswire
News headline image
Generate Biomedicines Inc. to Participate in September Investor Conferences
From Generate Biomedicines, Inc.
Via GlobeNewswire
News headline image
Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
From Generate Biomedicines, Inc.
Via GlobeNewswire